Gracell Biotechnologies Inc. (GRCL) Balance Sheet Quarterly

Gracell Biotechnologies Inc.

GRCL (NASDAQ)

(%)

Financials
Gracell Biotechnologies Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of CNY

Period Ending:	2023 (Q3) 09-30	2023 (Q2) 06-30	2023 (Q1) 03-31	2022 (Q4) 12-31	2022 (Q3) 09-30	2022 (Q2) 06-30	2022 (Q1) 03-31
Report Filing:	2023-09-30	2023-08-14	2023-03-31	2023-04-25	2022-09-30	2022-08-15	1234
Total Current Assets	1,774	1,247	1,325	1,496	1,670	1,739	1234
Cash and Short Term Investments	1,708	1,188	1,277	1,458	1,630	1,707	1234
Cash & Equivalents	1,677	-158	1,274	1,455	1,431	1,535	1234
Short Term Investments	30.46	3.57	3.57	3.56	198.2	172.2	1234
Receivables	0	0	0	0	0	0	1234
Inventory	0	0.002	0	0	0	0	1234
Other Current Assets	66.4	59.4	47.53	37.55	40.34	31.99	1234
Total Assets	1,890	1,378	1,474	1,656	1,838	1,899	1234
Total Non-Current Assets	115.7	130.5	148.8	160.5	168.4	159.9	1234
Property, Plant and Equipment	108.7	119.6	137.1	144.7	149.9	156.7	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	7.04	10.89	11.76	15.85	18.51	3.17	1234
Total Current Liabilities	229.5	193.8	211.6	220.6	246.5	217.1	1234
Accounts Payable	0	0	0	0	0	0	1234
Notes Payable/Short Term Debt	80.45	115.5	136.5	130	146.8	121.6	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	0	0	2.9	0	2.9	1234
Other Current Liabilities	149	78.34	75.07	87.75	99.74	92.64	1234
Total Liabilities	268.9	241.2	263.1	280.5	311.4	285.4	1234
Total Non-Current Liabilities	39.39	47.35	51.47	59.87	64.89	68.27	1234
Total Long Term Debt	35.37	42.5	46.09	52.99	56.98	60.51	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0	0	0	0	0	0	1234
Other Long Term Liabilities	4.02	4.85	5.38	6.88	7.91	7.76	1234
Total Equity	1,621	1,137	1,211	1,376	1,527	1,614	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	1,621	1,137	1,211	1,376	1,527	1,614	1234
Retained Earnings	-1,992	-1,924	-1,777	-1,625	-1,495	-1,323	1234
Accumulated Other Earnings	113.9	118.1	55.65	73.53	98.71	2.64	1234
Common Stock	0.324	0.225	0.223	0.223	0.223	0.223	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	3,498	3,060	2,987	2,927	3,021	2,936	1234
Total Liabilities & Total Equity	1,890	1,378	1,474	1,656	1,838	1,899	1234
Total Liabilities & Shareholders' Equity	1,890	1,378	1,474	1,656	1,838	1,899	1234
Total Investments	30.46	3.57	3.57	3.56	198.2	172.2	1234
Total Debt	115.8	158	182.6	183	203.8	182.1	1234
Net Debt	-1,562	316	-1,091	-1,272	-1,228	-1,353	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Gracell Biotechnologies Inc. Balance Sheet Statement Quarterly